PRESS RELEASE
News
-
-
-
REGULATED PRESS RELEASE
GUILLEMOT CORPORATION: Availability of the universal registration document including the 2024 annual financial report
Guillemot Corporation S.A. announces availability of 2024 Universal Registration Document. Includes annual financial report, corporate governance report, share buyback program details -
REGULATED PRESS RELEASE
GUILLEMOT CORPORATION : Mise à disposition du document d’enregistrement universel incluant le rapport financier annuel 2024
Guillemot Corporation S.A. annonce la mise \u00E0 disposition de son Document d'enregistrement universel 2024, incluant rapport financier et programme rachat d'actions -
-
PRESS RELEASE
Aspire Biopharma Holdings, Inc., Announces Institutional Review Board Approval for In-Human Clinical Trial of an Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation
Aspire Biopharma achieves IRB approval for Phase I clinical trial of fast-acting high-dose aspirin formulation, targeting rapid drug delivery and enhanced bioavailability for suspected acute myocardial infarction treatment -
-
-
-
